Total Valuation
Xtl Bio has a market cap or net worth of ₪19.87M. The enterprise value is 5.24M.
Market Cap₪19.87M
Enterprise Value5.24M
Share Statistics
Xtl Bio has 946,243,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding946,243,350
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Xtl Bio’s return on equity (ROE) is 27.44 and return on invested capital (ROIC) is -11253.33%.
Return on Equity (ROE)27.44
Return on Assets (ROA)-41.98
Return on Invested Capital (ROIC)-11253.33%
Return on Capital Employed (ROCE)6.65
Revenue Per Employee0.00
Profits Per Employee-696.90K
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Xtl Bio is ―. Xtl Bio’s PEG ratio is -0.00217.
PE Ratio―
PS Ratio0.00
PB Ratio-26.57
Price to Fair Value-26.57
Price to FCF-6.59
Price to Operating Cash Flow-5.89
PEG Ratio-0.00217
Income Statement
In the last 12 months, Xtl Bio had revenue of 0.00 and earned -6.97M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-1.69M
Pretax Income-759.00K
Net Income-6.97M
EBITDA-1.27M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Xtl Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change-59.18%
50-Day Moving Average1.93
200-Day Moving Average2.43
Relative Strength Index (RSI)48.70
Average Volume (3m)3.17M
Important Dates
Xtl Bio upcoming earnings date is Dec 5, 2023, Before Open (Confirmed).
Last Earnings DateMay 31, 2023
Next Earnings DateDec 5, 2023
Ex-Dividend Date―
Financial Position
Xtl Bio as a current ratio of 0.40, with Debt / Equity ratio of -105.91%
Current Ratio0.40
Quick Ratio0.40
Debt to Market Cap0.04
Net Debt to EBITDA-0.15
Interest Coverage Ratio-241.14
Taxes
In the past 12 months, Xtl Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Xtl Bio EV to EBITDA ratio is -5.48, with an EV/FCF ratio of -6.77.
EV to Sales0.00
EV to EBITDA-5.48
EV to Free Cash Flow-6.77
EV to Operating Cash Flow-6.77
Balance Sheet
Xtl Bio has ₪1.14M in cash and marketable securities with ₪138.00K in debt, giving a net cash position of ₪1.00M billion.
Cash & Marketable Securities₪1.14M
Total Debt₪138.00K
Net Cash₪1.00M
Net Cash Per Share<₪0.01
Tangible Book Value Per Share>-₪0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Xtl Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―